Area of research
Pediatrics, Perinatology and Child Health · Pulmonary and Respiratory Medicine
Research interest
Research interests include Neonatal Respiratory Health Research, Neonatal and fetal brain pathology, Infant Development and Preterm Care, and Infant Nutrition and Health.
Expectant Management vs Medication for Patent Ductus Arteriosus in Preterm Infants: The PDA Randomized Clinical Trial.
Association between medication for opioid use disorder during pregnancy and neonatal outcomes.
Antenatal Prediction of Early Cord Clamping among Infants Born Extremely Preterm.
Hydrocortisone in Preterm Infants and School-Age Functional Outcomes: Follow-Up of a Randomized Clinical Trial.
Accelerated Weaning of Opioids to Reduce Pharmacologic Exposure for Neonatal Opioid Withdrawal Syndrome: A Randomized Clinical Trial.
Temporal trends in outcomes for infants with neonatal opioid withdrawal managed with the Finnegan scoring tool: Insights from the INFORM NOW Study.
Maternal Area of Residence and Outcomes for Mother-Infant Dyads with Perinatal Opioid Exposure.
Whole-Body Hypothermia for Neonatal Encephalopathy in Preterm Infants 33 to 35 Weeks’ Gestation
Whole-Body Hypothermia for Neonatal Encephalopathy in Preterm Infants 33 to 35 Weeks' Gestation: A Randomized Clinical Trial.
Deferred Cord Clamping With High Oxygen in Extremely Preterm Infants
Early Intratracheal Budesonide to Reduce Bronchopulmonary Dysplasia in Extremely Preterm Infants
Extended Caffeine for Apnea in Moderately Preterm Infants
Early Intratracheal Budesonide to Reduce Bronchopulmonary Dysplasia in Extremely Preterm Infants: The Budesonide in Babies (BiB) Randomized Clinical Trial.
Short Duration of Antenatal Corticosteroid Exposure and Outcomes in Extremely Preterm Infants
Darbepoetin, Red Cell Mass, and Neuroprotection in Preterm Infants
Deferred Cord Clamping With High Oxygen in Extremely Preterm Infants: A Randomized Clinical Trial.
Short Duration of Antenatal Corticosteroid Exposure and Outcomes in Extremely Preterm Infants.
Association of a Count of Inpatient Morbidities with 2-Year Outcomes among Infants Born Extremely Preterm.
Expectant Management vs Medication for Patent Ductus Arteriosus in Preterm Infants
Extended Caffeine for Apnea in Moderately Preterm Infants: The MoCHA Randomized Clinical Trial.
Mode of delivery and outcomes among inborn extremely preterm singletons: A cohort study.
Trends in sex differences in neurodevelopmental outcomes among extremely preterm infants.
Outcomes of extremely preterm infants exposed to prolonged prelabor rupture of membranes before 24 weeks of gestation.
Cerebral injury and retinopathy as risk factors for blindness in extremely preterm infants.
Darbepoetin, Red Cell Mass, and Neuroprotection in Preterm Infants: A Randomized Clinical Trial.
Patent Ductus Arteriosus, Hydrocortisone, and Outcome among Infants Born Extremely Preterm: Secondary Analysis of the Hydrocortisone Trial.
NICHD Magnetic Resonance Brain Imaging Score in Term Infants With Hypoxic-Ischemic Encephalopathy: A Secondary Analysis of a Randomized Clinical Trial.
Optimizing Oxygen Strategy During Delayed Cord Clamping-Reply.
Inpatient morbidities and medical technology use at 2 years among extremely preterm infants.
Neonatal Neuroimaging Among Children Born Extremely Preterm and Motor Coordination Impairment at School-Age.